The bioluminescence reaction in vitro and in vivo.
A, simplified in vitro bioluminescent reaction mechanism.
The isoalloxazine ring of the flavin is oxygenated at position C-4a prior to
formation of the aldehyde hemiacetal
(47). The resolution of this
tetrahedral intermediate leads to the population of an excited state emitter
and ultimately light emission
(2,
44). B, in vivo, and
in the coupled assay in vitro, FMN is reduced by an oxidoreductase
enzyme via the oxidation of NADH or NAD(P)H
(10). Subsequently,
FMNH2 is transferred to bacterial luciferase either by diffusion or
by tunneling for the light emitting reaction.